Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi
Clicks: 288
ID: 115255
2008
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.6
/100
2 views
2 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
An early, 2-dose MV schedule was immunogenic, but a higher proportion of HIV-infected children remained susceptible to measles, compared with HIV-uninfected children (whether HIV exposed or HIV unexposed).Reference Key |
rf2008theevaluation
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Helfand RF;Witte D;Fowlkes A;Garcia P;Yang C;Fudzulani R;Walls L;Bae S;Strebel P;Broadhead R;Bellini WJ;Cutts F;; |
Journal | The Journal of infectious diseases |
Year | 2008 |
DOI | DOI not found |
URL | |
Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
male
Infant
Randomized Controlled Trial
Antibodies
Measles Vaccine / administration & dosage*
viral / blood
hiv-1 / immunology
hiv infections / immunology*
measles vaccine / immunology*
measles virus / immunology*
kaplan-meier estimate
measles / prevention & control*
vaccination*
malawi
felicity cutts
pmid:18828743
doi:10.1086/592756
rita f helfand
desiree witte
demography
immunocompromised host / immunology
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.